Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy

被引:14
|
作者
Klopotowski, Mariusz [1 ]
Kwapiszewska, Aleksandra [1 ]
Kukula, Krzysztof [1 ]
Jamiolkowski, Jacek [2 ]
Dabrowski, Maciej [1 ]
Derejko, Pawel [3 ]
Oreziak, Artur [4 ]
Baranowski, Rafal [4 ]
Spiewak, Mateusz [5 ]
Marczak, Magdalena [5 ]
Klisiewicz, Anna [6 ]
Szepietowska, Barbara [7 ]
Chmielak, Zbigniew [1 ]
Witkowski, Adam [1 ]
机构
[1] Inst Cardiol, Dept Intervent Cardiol & Angiol, Warsaw, Poland
[2] Med Univ Bialystok, Dept Populat Med & Civilizat Dis Prevent, Bialystok, Poland
[3] Medicover Hosp, Dept Cardiol & Internal Med, Warsaw, Poland
[4] Inst Cardiol, Dept Cardiac Arrhythmias, Warsaw, Poland
[5] Inst Cardiol, Magnet Resonance Unit, Warsaw, Poland
[6] Inst Cardiol, Dept Congenital Heart Dis, Warsaw, Poland
[7] Univ Rochester, Med Ctr, Dept Med, Heart Res Follow Up Program, Rochester, NY 14642 USA
关键词
atrial fibrillation; hypertrophic cardiomyopathy; risk factors; MAGNETIC-RESONANCE; METABOLIC SYNDROME; IMPACT; PROFILE; DEATH;
D O I
10.1002/clc.23050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hypothesis Atrial fibrillation (AF) is a common complication in patients with hypertrophic cardiomyopathy (HCM) and may contribute to high cardiovascular morbidity and mortality. Therefore, it is important to assess parameters associated with AF in HCM patients. The aim of the study was to evaluate AF prevalence in patients with HCM and to investigate risk factors for AF. Methods Results Five hundred and forty-six HCM patients aged below 65 were included into analysis. Clinical and echocardiographic parameters were analyzed. In 141 patients (25.8%) AF episodes were recorded. The following factors were identified as risk factors for AF in patients with HCM: age >= 45 years (OR 2.38, CI 1.40-4.05, P = 0.001), past history of presyncope or syncope (OR 2.25, CI 1.35-3.74, P = 0.002), non-sustained ventricular tachycardia (nsVT) (OR 2.70, CI 1.60-4.57, P < 0.001), left atrium diameter during first assessment (OR 1.065, CI 1.03-1.11, P = 0.001), left atrium diameter at the last assessment before AF occurrence (OR 1.10, CI 1.06-1.14, P < 0.001) and left ventricular ejection fraction at the last assessment before AF occurrence (CI 0.96, CI 0.94-0.98, P = 0.001). Conclusions We confirm that AF is a common complication for patients with HCM. Identification of patients with high risk for AF and implementation of preventive strategies may reduce AF occurrence and its complications.
引用
收藏
页码:1336 / 1340
页数:5
相关论文
共 50 条
  • [1] Atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy:clinical characteristics and risk factors
    伍熙
    [J]. China Medical Abstracts (Internal Medicine), 2017, 34 (02) : 98 - 99
  • [2] Risk factors for atrial fibrillation in hypertrophic cardiomyopathy
    Philipson, Daniel J.
    Rader, Florian
    Siegel, Robert J.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (06) : 658 - 665
  • [3] Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
    Mandes, Leonard
    Rosca, Monica
    Ciuperca, Daniela
    Calin, Andreea
    Beladan, Carmen C.
    Enache, Roxana
    Cuculici, Andreea
    Baicus, Cristian
    Jurcut, Ruxandra
    Ginghina, Carmen
    Popescu, Bogdan A.
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [4] Risk factors associated with atrial fibrillation in hypertrophic cardiomyopathy
    Dalos, D.
    Dachs, T.
    Srdits, M.
    Stix, L.
    Kronberger, C.
    Rettl, R.
    Binder, C.
    Duca, F.
    Schrutka, L.
    Eslam, R. Badr
    Kastner, J.
    Bonderman, D.
    Gwechenberger, M.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S90 - S91
  • [5] Risk factors associated with atrial fibrillation in hypertrophic cardiomyopathy
    Dalos, D. Daniel
    Dachs, T. M.
    Srdits, M.
    Stix, L.
    Kronberger, C.
    Rettl, R.
    Binder, C.
    Duca, F.
    Schrutka, L.
    Eslam, R. Badr
    Kastner, J.
    Bonderman, D.
    Gwechenberger, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 250 - 250
  • [6] Clinical risk factors of new onset atrial fibrillation in patient with hypertrophic cardiomyopathy
    Choi, J-H Jung-Hyun
    Kim, B. W.
    Lee, S. H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 84 - 84
  • [7] Transesophageal Echocardiographic Features in Patients With Hypertrophic Cardiomyopathy and Paroxysmal Atrial Fibrillation
    Yagishita, Atsuhiko
    Takahashi, Yoshihide
    Kusa, Shigeki
    Ookubo, Kenji
    Fujino, Tadashi
    Kuwahara, Taishi
    Takahashi, Atsushi
    Hirao, Kenzo
    Isobe, Mitsuaki
    [J]. JOURNAL OF CARDIAC FAILURE, 2010, 16 (09) : S177 - S177
  • [8] Echocardiographic assessment of atrial function in patients with hypertrophic cardiomyopathy with and without paroxysmal atrial fibrillation
    Morbeck Teixeira, Kamilla Leite
    Correia, Edileide de Barros
    Tressino, Cintia Galhardo
    Pecanha, Marcela Momesso
    Melchior, Walter Antonio
    de Mattos Barretto, Rodrigo Bellio
    de Medeiros, Bruna Gomes
    Le Bihan, David
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2022, 41 (09) : 771 - 779
  • [9] Clinical risk factors of new onset atrial fibrillation in patient with hypertrophic cardiomyopathy.
    Choi, J-H Jung-Hyun
    Kim, B. W.
    Choi, J. H.
    Hong, T. J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 359 - 359
  • [10] NOVEL INTEGRATED IMAGING PARAMETERS FOR RISK STRATIFICATION OF ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    Parisi, F.
    La Franca, E.
    Giovanni, G.
    Bellavia, D.
    Pistelli, L.
    Zito, C.
    Carerj, S.
    Cipriani, M.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26